当前蛋白身份:P53667 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
3S95 Crystal structure of the human LIMK1 kinase domain in complex with staurosporine 提交 2011-05-31 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 330–637(308 aa) 片段:kinase domain (residue 330-637)
未记录 STU STAUROSPORINE × 1 NA SODIUM ION × 1 GOL GLYCEROL × 9 CL CHLORIDE ION × 1 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
分辨率 1.65 Å R-free 0.181
3S95 Crystal structure of the human LIMK1 kinase domain in complex with staurosporine 提交 2011-05-31 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 330–637(308 aa) 片段:kinase domain (residue 330-637)
未记录 STU STAUROSPORINE × 1 NA SODIUM ION × 1 GOL GLYCEROL × 2 CL CHLORIDE ION × 1 TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;293.15 K;24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
分辨率 1.65 Å R-free 0.181
5HVJ Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP 提交 2016-01-28 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 329–638(310 aa)
突变:D460N ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;298 K;18-24% PEG 3350, 0.2 M potassium citrate
分辨率 2.20 Å R-free 0.252
5HVJ Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP 提交 2016-01-28 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 329–638(310 aa)
突变:D460N 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;298 K;18-24% PEG 3350, 0.2 M potassium citrate
分辨率 2.20 Å R-free 0.252
5HVK Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1 提交 2016-01-28 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 329–638(310 aa) 片段:UNP residues 329-638
突变:D460N 非标准单体:是(mmCIF未提供具体位点) ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.2-1.4 M tri-Sodium citrate, 0.1 M sodium acetate, pH 5.5. 4 crystals used.
分辨率 3.50 Å R-free 0.310
5HVK Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1 提交 2016-01-28 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 329–638(310 aa) 片段:UNP residues 329-638
突变:D460N 非标准单体:是(mmCIF未提供具体位点) ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;1.2-1.4 M tri-Sodium citrate, 0.1 M sodium acetate, pH 5.5. 4 crystals used.
分辨率 3.50 Å R-free 0.310
5L6W Structure Of the LIMK1-ATPgammaS-CFL1 Complex 提交 2016-05-31 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 L 330–637(308 aa)
未记录 AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;35% pentaerythritol propoxylate 5/4, 0.1 M HEPES pH 7.5, 0.2 M potassium chloride
分辨率 2.53 Å R-free 0.284
5NXC LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736 提交 2017-05-10 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 L 330–637(308 aa) 片段:UNP residues 330-637
未记录 9DB (2~{R})-2-azanyl-2-cyclohexyl-~{N}-[2-(1-methylpyrazol-4-yl)-9-oxidanylidene-3,10,11-triazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13),11-pentaen-6-yl]ethanamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;0.1 M HEPES pH 7.0 0.2 M MgCl2 10% PEG8K
分辨率 2.25 Å R-free 0.298
6WLY PAK4 kinase domain in complex with LIMK1 Thr508 substrate peptide 提交 2020-04-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 503–512(10 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;0.1M Tris-HCl, 2M Na acetate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K, 2mM peptide
分辨率 1.90 Å R-free 0.205
7ATS The LIMK1 Kinase Domain Bound To LIJTF500127 提交 2020-10-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 330–637(308 aa)
未记录 RXQ N-[3-[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]benzenesulfonamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG3350 0.1 M bis-tris-propane pH 7.5 0.2 M potassium thiocyanate 10% ethylene glycol
分辨率 2.80 Å R-free 0.312
7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 提交 2020-10-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomer(1) 与蛋白数一致
链 A 330–637(308 aa)
未记录 RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9 0.2 M NaCl 8% jeffamine M-600 0.005 M iron chloride
分辨率 2.80 Å R-free 0.316
7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 提交 2020-10-30 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomer(1) 与蛋白数一致
链 B 330–637(308 aa)
未记录 RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9 0.2 M NaCl 8% jeffamine M-600 0.005 M iron chloride
分辨率 2.80 Å R-free 0.316
7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 提交 2020-10-30 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomer(1) 与蛋白数一致
链 C 330–637(308 aa)
未记录 RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9 0.2 M NaCl 8% jeffamine M-600 0.005 M iron chloride
分辨率 2.80 Å R-free 0.316
7ATU The LIMK1 Kinase Domain Bound To LIJTF500025 提交 2020-10-30 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomer(1) 与蛋白数一致
链 D 330–637(308 aa)
未记录 RXN (S)-2-benzyl-6-(8-chloro-5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277 K;0.1 M citrate pH 5.9 0.2 M NaCl 8% jeffamine M-600 0.005 M iron chloride
分辨率 2.80 Å R-free 0.316
7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 提交 2020-12-13 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 330–637(308 aa)
未记录 T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 EDO 1,2-ETHANEDIOL × 3 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
分辨率 2.80 Å R-free 0.286
7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 提交 2020-12-13 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 330–637(308 aa)
未记录 T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
分辨率 2.80 Å R-free 0.286
7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 提交 2020-12-13 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 330–637(308 aa)
未记录 T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
分辨率 2.80 Å R-free 0.286
7B8W Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470 提交 2020-12-13 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 330–637(308 aa)
未记录 T3B 2-(2-methylpropanoylamino)-~{N}-[2-[(phenylmethyl)-[4-(phenylsulfamoyl)phenyl]carbonyl-amino]ethyl]-1,3-thiazole-5-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;277.15 K;0.2M Ammonium Citrate dibasic, 20% w/v PEG 3350
分辨率 2.80 Å R-free 0.286
8AAU LIM Domain Kinase 1 (LIMK1) bound to LIMKi3 提交 2022-07-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 L 330–637(308 aa)
未记录 EDO 1,2-ETHANEDIOL × 1 LH0 ~{N}-[5-[2-[2,6-bis(chloranyl)phenyl]-5-[bis(fluoranyl)methyl]pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methyl-propanamide × 1 SO4 SULFATE ION × 3 MG MAGNESIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 4.5;277 K;0.1 M acetate pH 4.5, 0.2 M lithium sulfate, 12% PEG8K
分辨率 1.74 Å R-free 0.240